Llwytho...
AB086. HLA-B*1502 and HLA-B*5801 genotyping for the prevention of severe cutaneous adverse drug reactions in a Children’s Hospital
BACKGROUND: Severe cutaneous adverse drug reactions (SCARs) are life-threatening. This includes Stevens-Johnson syndrome (SJS) and the more severe phenotype, toxic epidermal necrolysis (TEN). Clinical studies have shown that HLA-B*1502 allele is strongly associated with carbamazepine (CBZ) induced S...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ann Transl Med |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
AME Publishing Company
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5641803/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.s086 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|